Nanobiotix and Societe Generale Disclose Voting Rights and Share Capital Figures

Nanobiotix, a Paris‑based late‑stage biotechnology firm listed on Euronext Paris and Nasdaq, published a regulatory filing on 30 July 2026 reporting 50,825,682 shares outstanding and total voting rights of 54,486,890 (exercisable 54,464,772) as of 30 June 2026. The disclosure follows French Commercial Code article L. 233‑8 II and AMF regulation article 223‑16.

Societe Generale, a French multinational bank, released its share‑holding information on 29 July 2026, stating that its capital comprised 750,900,671 shares and that total voting rights amounted to 834,887,878 as of 27 July 2026, also in compliance with the same French legal provisions. Both companies provided contact details for investor relations and media inquiries in the filings.